Opus Genetics (IRD) PT Lowered to $9 at RBC Capital
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Price: $4.25 +10.97%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
RBC Capital analyst Lisa Walter lowered the price target on Opus Genetics (NASDAQ: IRD) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- GitLab Inc (GTLB) PT Raised to $52 at Piper Sandler
- Comstock Resources (CRK) PT Raised to $17 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
